Hong Kong Customs stated that Sudan Red was detected in Medicube cream, while the brand responded that the test results showed no detection.
Recently, Hong Kong Customs of China issued a public announcement stating that the PDRN Collagen Capsule Cream under the South Korean beauty brand Medicube was found to contain the banned substance Sudan Red during safety testing, suspected of violating the Consumer Goods Safety Ordinance. Customs also discovered that the product packaging lacked Chinese warning labels, potentially violating relevant subsidiary regulations. The product in question highlights PDRN repair benefits and was previously involved in a public controversy over raw materials containing Sudan Red in 2025. In response to these test results, Medicube issued a statement through official channels, stating that tests conducted by accredited testing agencies in South Korea showed "not detected" for Sudan Red in the relevant products, and the test reports have been submitted to Hong Kong Customs for reference. Brand customer service stated that the company conducted internal testing again in 2026 year 6 month, with all results negative, and is currently cooperating with Customs for review and necessary additional verification. Regarding label compliance issues, the brand stated it is assessing local regulations and will make adjustments in accordance with the law if necessary. It is worth noting that despite facing regulatory controversy, the product in question continues to be sold normally at Medicube's overseas flagship store. The brand revealed that, based on the principle of prudence, the formula for its products sold in Hong Kong, China, has been updated since 2026 year 3 month. This incident has once again drawn market attention to the traceability of cosmetic raw materials and differences in cross-border regulatory standards. As an industrial dye, Sudan Red is strictly prohibited from being added to cosmetics due to its potential carcinogenic risk. Regarding the significant discrepancy between the test results of the brand and the regulatory authorities, industry observers pointed out that this may involve complexities such as sampling batches, sensitivity of testing methods, or supply chain contamination, and the final conclusion awaits further investigation and confirmation by officials. If mishandled, this incident will have a sustained negative impact on brand reputation and consumer trust, while also reminding multinational beauty companies to strengthen compliance management and transparency building in their global supply chains.